These studies reinforced the role of ALDH1 family enzymes in chemoresistance and reinforced the hypothesis that therapeutic approaches targeting the ALDH family may ameliorate clinical outcomes in cancer patients. The gene discussed is ALDH1A1; the disease is cancer.